Cargando…
Medicines for Obesity: Appraisal of Clinical Studies with Grading of Recommendations, Assessment, Development, and Evaluation Tool
We evaluated the quality of evidence from phase III/IV clinical trials of drugs against obesity using the principles of Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) tool. Our systematic review evaluates the quality of clinical evidence from existing clinical trials and...
Autores principales: | Karavia, Eleni A., Giannopoulou, Panagiota C., Konstantinopoulou, Vassiliki, Athanasopoulou, Katerina, Filippatos, Theodosios D., Panagiotakos, Demosthenes, Kypreos, Kyriakos E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9919203/ https://www.ncbi.nlm.nih.gov/pubmed/36771314 http://dx.doi.org/10.3390/nu15030606 |
Ejemplares similares
-
Adverse Drug Reactions in Relation to Clozapine Plasma Levels: A Systematic Review
por: Skokou, Maria, et al.
Publicado: (2022) -
Apolipoprotein E in diet-induced obesity: a paradigm shift from conventional perception
por: E. Kypreos, Kyriakos, et al.
Publicado: (2018) -
Peroxisome Proliferator-Activated Receptor α in Lipoprotein Metabolism and Atherosclerotic Cardiovascular Disease
por: Fuior, Elena Valeria, et al.
Publicado: (2023) -
Towards a Better Primary Healthcare in Europe: Shifts in Public Health Nutrition Policies
por: Panagiotakos, Demosthenes B., et al.
Publicado: (2020) -
Anacetrapib, a New CETP Inhibitor: The New Tool for the Management of Dyslipidemias?
por: Filippatos, Theodosios D., et al.
Publicado: (2017)